EVOTEC SEINH O.N. news, videos and press releases - Page 3
For more news please use our advanced search feature.
EVOTEC SEINH O.N. - More news...
EVOTEC SEINH O.N. - More news...
- Evotec Announces CEO Transition
- EQS-News: Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes
- Evotec receives US$ 2.5 M Grant to Leverage Human iPSC-Derived Teratogenicity Platform for Global Health Programmes
- EQS-News: Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases
- Evotec Enters Partnership with Charité to Expand Molecular Patient Database in Autoimmune Diseases
- EQS-News: Evotec-partner Jingxin receives approval for EVT201 in China
- Evotec-partner Jingxin Receives Approval for EVT201 in China
- EQS-News: Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day
- Evotec Presents Precision Medicine Platforms for Accelerated Pipeline Building at Capital Markets Day
- EQS-News: Evotec SE reports results for the first nine months 2023 and provides corporate update
- Evotec SE Reports Results for the First Nine Months 2023 and Provides Corporate Update
- EQS-News: Evotec and Dewpoint Therapeutics enter strategic partnership in oncology
- Evotec and Dewpoint Therapeutics Enter Strategic Partnership in Oncology
- EQS-News: Evotec SE to announce results for the first nine months 2023 on 08 November 2023
- Evotec SE to announce results for the first nine months 2023 on 08 November 2023
- EQS-News: Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
- Evotec, ClavystBio, Leaps by Bayer, Lightstone Ventures and Polaris Partners launch '65LAB'
- EQS-News: Evotec SE: Launch of partnering agreement to strengthen biotech innovators in shared R&D economy
- Evotec SE: Launch of Partnering Agreement to Strengthen Biotech Innovators in Shared R&D Economy
- EQS-News: Evotec and Novo Nordisk launch LAB eN² to accelerate translation in cardiometabolic diseases
- Evotec and Novo Nordisk Launch LAB eN² to Accelerate Translation in Cardiometabolic Diseases
- EQS-News: Evotec SE reports results for the first half-year 2023 and provides corporate updates
- Evotec SE Reports Results for the First Half-year 2023 and Provides Corporate Updates
- EQS-News: Evotec SE reports first half-year 2023 results on 29 August 2023
- Evotec SE Reports First Half-Year 2023 Results on 29 August 2023
- EQS-News: Evotec provides update on financial impact of cyber-attack
- EQS-Adhoc: Evotec provides update on financial impact of cyber-attack
- Evotec Provides Update on Financial Impact of Cyber-Attack
- Evotec Provides Update on Financial Impact of Cyber-Attack
- EQS-News: Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership